,44 This evidence suggests that MTRs play an important role in the downregulation of immune and antitumor genes such as CCL5 and IFN-γ, leading to reduced levels of cytotoxic lymphocytes and a more aggressive disease progression capacity in patients with CRC of AFR ancestry. This evidence concerns the gene IFNG and colorectal carcinoma.